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ABSTRACT 30 
Introduction: In 2016, approximately 1.7 million new cases of cancer were diagnosed. Cancer 31 
patients can have physical, functional, and psychosocial issues when dealing with cancer 32 
treatment. Telehealth has been effectively introduced to help deliver treatment to patients 33 
suffering from chronic disease, however, there is little consensus on its effectiveness in 34 
administering socio-behavioral cancer treatments.  Thus, this study determines the benefits of 35 
telehealth-based interventions providing emotional and symptom support in improving quality of 36 
life (QOL) among cancer patients. 37 
Methods: Two researchers conducted comprehensive searches on PubMed, SCOPUS, Medline, 38 
PsycINFO, ERIC, Psychology and Behavioral Collection, and Medline Complete. Key search 39 
terms included telehealth or telemedicine and quality of life and cancer. Manuscripts were 40 
included if they assessed a telehealth delivered intervention for adult cancer patients and 41 
provided a QOL assessment. Data were extracted to calculate mean effect sizes for QOL 42 
measures on the effectiveness of telehealth relative to usual care for cancer treatments. 43 
Results: Out of 414 articles identified in our initial search, nine articles fit our inclusion criteria. 44 
Both telehealth (Hedges g = 0.211, p=0.016) and standard of care (Hedges g = 0.217, p<0.001) 45 
cancer treatment delivery methods demonstrated small but statistically significant improvements 46 
in QOL measures. However, there were no statistically significant differences in effectiveness 47 
between the telehealth interventions and usual care (p=0.76). 48 
Conclusions: The results indicate that telehealth interventions are as effective at improving QOL 49 
scores in patients undergoing cancer treatment as in-person usual care. Further studies should be 50 
undertaken on different modalities of telehealth to determine its appropriate and effective use in 51 
interventions to improve the quality of life for cancer patients undergoing treatment. 52 
 53 
54 
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INTRODUCTION 55 
Nearly two million new cases of cancer are diagnosed every year in the United States.1 Cancer 56 
patients can experience multiple issues during treatment, including physical, functional, and 57 
psychosocial symptoms and complications.2–7 Cancer diagnoses can lead to severe psychological 58 
distress and disrupt patients’ lives, increasing strains on work, family, and social 59 
relationships.2,8,9 Improved management of emotional distress and symptoms, especially after 60 
new diagnoses and treatments, could significantly improve quality of life for cancer patients.10 61 
Furthermore, the need for effective and cost-efficient interventions to address psychosocial 62 
symptoms resulting from treatment will increase in the future with the aging demographic 63 
distribution in the US and consequent increase in cancer diagnoses.11 64 
 65 
Telehealth has been effectively used to help manage many chronic conditions and to improve 66 
compliance with treatment and patients’ overall well-being.4 The terms ‘telehealth’ or 67 
‘telemedicine’ are often used interchangeably and can have multiple definitions. Telemedicine is 68 
often used to refer to diagnosis and monitoring technology, whereas telehealth may be used to 69 
include management, education, and other allied health care services.12 The Health Resources 70 
and Services Administration defines telehealth as the use of technology to deliver health care, 71 
health information, or health education at a distance.13 Telehealth technologies, including 72 
telephone, videoconferencing, and internet-based interventions, have the capability of bringing 73 
services into the patient’s home and helping them manage their symptoms without needing to be 74 
physically present at a hospital or clinic.3,10 Telemedicine patients have reported good acceptance 75 
of and satisfaction with the use of technology in comparison with in-person visits.14,15 Providing 76 
patients greater access to symptom management and emotional support services may lead to 77 
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patients taking a more active role in their health care and could improve patient outcomes 78 
including overall quality of life (QOL).3 79 
 80 
The purpose of this systematic review and meta-analysis is to examine the effect that telehealth 81 
interventions providing emotional and symptom management have on cancer patients’ QOL. To 82 
our knowledge, there has been no study done to date that has examined the overall effect of 83 
supporting patients in the management of their symptoms via telehealth technology in 84 
comparison to in-person usual care (UC). We determine whether interventions utilizing 85 
telehealth-delivered support are more effective in improving QOL versus UC from baseline until 86 
the end of the intervention period. 87 
 88 
METHODS 89 
The recommendations outlined in the preferred reporting items for systematic reviews and meta-90 
analyses (PRISMA) statement were used to guide this systematic review and meta-analysis.16  91 
 92 
2.1 Data Acquisition 93 
An electronic database search was initially conducted from inception to December, 31 2016 by 94 
two of the coauthors using the following databases: National Library of Medicine Catalog 95 
(Medline/PubMed), SCOPUS, the Cumulative Index for Nursing and Allied Health Literature 96 
(CINAHL), Ebsco Health (Medline complete). The initial key-term search consisted of: 97 
“telehealth OR telemedicine” AND “Cancer” AND “quality of life OR assessment”.  After the 98 
initial search, article titles and abstracts were inspected for relevance to the inclusion and 99 
exclusion criteria, followed by obtaining full-texts for identified manuscripts. Manuscripts were 100 
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then further scrutinized for inclusion and exclusion criteria post-retrieval. Reference lists of full-101 
text manuscripts were then hand-searched and cross-referenced for potentially relevant papers.  102 
Another separate search on the Cochrane Library was conducted for systematic reviews 103 
containing similar content.  Relevant systematic reviews were then obtained and cross-referenced 104 
for additional manuscripts missed during the original search.  Consensus among all the authors 105 
was then sought for an article’s final inclusion in the meta-analysis. 106 
 107 
2.2 Inclusion and Exclusion Criteria 108 
 All manuscripts included in the systematic review and meta-analysis must have been 109 
published in a peer-reviewed journal and met the following inclusion criteria: 1) Patients 110 
included must have had any form of cancer and been undergoing active treatment; 2) Patients 111 
must have been adults, 18 years of age or older; 3) Interventions must have used some form of 112 
telehealth/telemedicine, including but not limited to telephone calls and/or web based 113 
interventions; 4) The focus of each intervention must have been on emotional support or self-114 
management of symptoms through counseling, educational intervention or telepsychiatry; and 5) 115 
Studies must have used a measurable QOL scale or questionnaire. Studies were excluded if they: 116 
1) Were written in a language other than English; 2) Included pediatric patients; 3) If they 117 
assessed the efficacy of palliative care; or 4) Combined in-person and telehealth in the same 118 
intervention. 119 
 120 
2.3 Data extraction and analysis 121 
For the systematic review portion of this study, descriptive data were extracted from each of the 122 
included articles pertaining to their methodology and results. Numerical data extracted for the 123 
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meta-analysis included sample sizes, QOL measures means and standard deviations from 124 
baseline and post-intervention as well as effect sizes for each study whenever data were 125 
available. If effect size results were not reported, they were conservatively estimated based on 126 
the obtainable data from each included study. Following the retrieval of study data, standardized 127 
mean differences between baseline and post-test while adjusting for small sample bias (Hedges 128 
g) were calculated for telehealth interventions and usual care (UC) separately.17 A mean effect 129 
size (∆) for both telemedicine and UC was determined using a random effects model due to the 130 
uncertainty of evaluating a homogenous population.18 Heterogeneity was assessed via I2 and Q-131 
statistics. To gauge the impact of bias from unpublished studies on the mean effect size, the fail-132 
safe N was also evaluated.18 All effect-size data and heterogeneity statistics were calculated with 133 
the Comprehensive Meta-Analysis (V3.3.070, Biostat, Inc., Englewood, NJ) software package. 134 
Effect size data were interpreted as 0.1-0.3=small, 0.3-0.5=moderate and >0.5= large effects. 19 135 
After effect size calculations were acquired, independent t-tests were then used to determine if 136 
differences existed between the effect sizes of the telemedicine and UC cancer delivery 137 
interventions utilizing the IBM Statistical Package for the Social Sciences (SPSS) software 138 
(Version 24.0, IBM, Inc., Armonk, NY). The significance level was set to p<.05 for all statistical 139 
analyses a-priori.  140 
 141 
RESULTS 142 
Figure 1 is a flow diagram of our article selection process. Our initial search for articles using 143 
our search terms within the designated literature databases yielded a total of 414 articles. A 144 
search in the Cochrane database for systematic reviews containing similar content provided 5 145 
systematic reviews, and all the references within the systematic reviews, totaling 370 article 146 
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titles, were screened. After titles and abstracts were screened, 57 articles were retained to be 147 
assessed by two authors to ensure consensus on inclusion. After duplicates and those that did not 148 
fit the inclusion criteria were excluded, full text assessments were performed on the 21 149 
remaining articles. Nine articles were excluded due to the patient population being cancer 150 
survivors and not in active treatment, and one article was excluded because the intervention was 151 
exercise-based. Nine articles (Table 1) ultimately fit all systematic review and meta-analysis 152 
criteria.  153 
 154 
Five out of nine articles used telephone-based interventions (56%), another three studies used 155 
web-based designs or connected devices (33%) and one (11%) utilized videoconferencing. The 156 
time period for the studies varied, ranging from 6 weeks to one year. One article did not 157 
specifically report the time period from baseline to final assessment, but stated it was one month 158 
after treatment.20 The mean age of the patients within the 9 articles ranged from 53 to 67 years of 159 
age. Five of the articles focused on specific cancers, e.g., colorectal, breast, and head and neck 160 
cancers,7,21–24 whereas three articles included three or more types of cancer within their study 161 
population.20,25,26 Pfeifer et al. (2015) included both breast and prostate cancer patients. 27 162 
 163 
 Of the nine articles included, only one had statistically significant results for overall QOL scores 164 
from baseline to end of the study period and did not have a comparable control group. 20 Two 165 
articles did find clinically significant improvements in the intervention effect on QOL, but were 166 
not statistically significant. Berry et al. (2014) did not find statistically significant between-group 167 
changes in QOL overall, but did report statistical significance for a sub-analysis by age. There 168 
was a statistically significant intervention effect for those ≥50 years of age, though not for those 169 
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younger.26 Hegel et al (2011) found statistically significant improvements for the intervention 170 
group compared to the usual care control for overall QOL as well as emotional and social well-171 
being subscales at 6 weeks. However, after the intervention was completed, the 12-week end of 172 
study QOL scores were not statistically significant between groups.22 A similar effect was found 173 
in Pfeifer’s (2015) study, as there was no statistically significant difference between groups in 174 
the overall QOL score, although there were statistically significant differences in physical well-175 
being after the intervention.27 The Ruland (2013) and Rhyanen (2013) studies reported no 176 
statistically significant between-group results for the telehealth intervention on QOL. Both 177 
studies did find other statistically significant results related to lower anxiety and depression scale 178 
scores for those in the intervention groups compared to the usual care controls over the study 179 
period.23,24 Ruland et al. (2013) found that the intervention group had significant decreases in 180 
depression scale scores and did not have the significant decreases that were found over time in 181 
the control group for QOL and self-efficacy scores.23 Rhyanen et al. (2013) collected data more 182 
frequently and were able to associate QOL changes with events such as increases in QOL after 183 
surgery and decreases in QOL at the end of radiotherapy.24 The intervention group had a 184 
continual decrease in anxiety over time, whereas the control group had greater anxiety before 185 
surgery and chemotherapy, as well as during chemotherapy treatments.24 In the study, anxiety 186 
was statistically significantly associated with overall QOL scores and physical, psychological, 187 
and spiritual well-being subscales.24 188 
  189 
In total, 16 individual effect sizes—nine for telehealth interventions and seven for UC—were 190 
calculated.  Across the nine studies included in the meta-analysis, 680 patients received 191 
telehealth cancer interventions, while 602 patients received UC. The distribution for all 192 
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unweighted effect sizes calculated are displayed on a forest plot in Figure 2. The summary 193 
statistics for the mean effect sizes for telehealth and UC with their 95% confidence intervals, 194 
heterogeneity statistics and fail safe N calculations are reported in Table 2. Both telehealth (Δ = 195 
0.211, p=0.016) and UC (Δ = 0.217, p<0.001) demonstrated small but statistically significant 196 
mean effects compared to baseline QOL across the included studies. They each had relatively 197 
low Q and I2 values indicating homogeneity across the included studies (refer to supplemental 198 
materials for funnel plot files).  No statistically significant differences were present between the 199 
mean effect sizes of telehealth and UC interventions (t= -0.31, p=0.76). 200 
 201 
Multiple sensitivity secondary analyses were performed by revising the meta-analysis to include 202 
only those articles that used the Functional Assessment for Cancer Therapy (FACT) scale for 203 
quality of life. Including only these six studies increased the effect size of the intervention group 204 
(Δ = 0.338, p=0.006), and the effect size was considered moderate. The control group in this 205 
analysis had a smaller increase in effect size (Δ = 0.256, p=0.013). This suggests that using 206 
different scales for measuring QOL may affect the measurable impact of the telehealth 207 
interventions. We also stratified the meta-analysis to compare telephone interventions (n=5) 208 
versus internet/device interventions (n=4). This resulted in telephone interventions having a 209 
larger, moderate effect size (Δ=0.325, p=0.028) than the internet/device interventions (Δ=0.092, 210 
p=0.341). However, these were not statistically different (t= -0.584, p = 0.577), likely due to the 211 
low sample of studies.  212 
 213 
DISCUSSION 214 
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Our study performed a systematic review of peer-reviewed studies that utilized telehealth 215 
interventions to improve emotional support and symptom self-management for patients receiving 216 
treatment for cancer. Our findings demonstrated a statistically significant, albeit small increase in 217 
QOL for the telehealth intervention group relative to baseline across the nine studies in the meta-218 
analysis. The UC group had a similar, statistically significant improvement across seven studies, 219 
but we found telehealth to be non-inferior to UC in improving quality of life for cancer patients. 220 
Sensitivity analysis suggested that telephone-based interventions may be superior to 221 
internet/device interventions for cancer patients.  222 
 223 
The studies in our meta-analysis and systematic review were relatively homogenous as 224 
demonstrated by funnel plots (refer to supplemental materials). Harrison et al. (2011) was the 225 
only potential outlier showing significantly improved effectiveness of telehealth versus UC; 226 
however, this was the only study analyzing patients with colorectal cancer.21 It is possible that 227 
telehealth-based psychosocial treatments would vary in effectiveness across cancer diagnoses. 228 
Unfortunately, there has been insufficient research to demonstrate this. 21  229 
 230 
Our findings are consistent with prior research demonstrating non-inferiority of tele-psychiatry 231 
interventions versus face-to-face treatment.28–30 Thus, by maintaining a comparable QOL while 232 
averting the need to travel for in-person therapy or treatment, the use of telehealth for 233 
psychosocial support of cancer patients is likely to be cost-effective. Furthermore, telehealth may 234 
be effective in improving outcomes other than QOL, however, such as patient satisfaction and 235 
acceptability of the new modality.31 For example, a systematic review conducted by Calvin et al 236 
suggested that most patients accept and are satisfied with many forms of telehealth interventions 237 
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they received.32 Another study showed that telehealth did not lead to lower patient satisfaction in 238 
communicating with their providers. 33 239 
 240 
Our inclusion criteria stated that all articles must have an overall quality of life measurement. Of 241 
the nine studies in our systematic review, the majority (67%) used the FACT instrument—either 242 
the general or cancer-specific FACT instrument—as shown in Table 1. The general FACT scale 243 
was developed and validated between 1987 and 1992, in a five-phase process, including item 244 
generation, item review and reduction, scale construction and piloting, initial evaluation, and 245 
additional evaluation.34 FACT-G is a 27-item instrument that has subscale scores for physical, 246 
functional, social, emotional well-being and satisfaction with treatment.34 Cancer-specific FACT 247 
scales include those questions that are in the FACT-G but have additional questions that are 248 
cancer specific, such as for colorectal cancer (FACT-C), breast cancer (FACT-B), and head and 249 
neck cancer (FACT-HN).35–38 Berry et al.(2014) used the Symptom Distress Scale (SDS), which 250 
has 15 items—the 13 included in the usual SDS instrument and an additional 2 questions related 251 
to sexual activity and interest, and fever and chills.26  The SDS used a 5-point Likert scale 252 
ranging from no distress or normal (0) to severe distress (5), creating a total SDS score from an 253 
unweighted summation of the scores.39 Ruland et al. (2013) also used a 15-dimensional self-254 
administered instrument for measuring QOL based on similar symptoms to the SDS, but using a 255 
5-point Likert score where higher scores denoted improved health status.23, 40 The breast cancer 256 
version of the Quality of Life Instrument was used by Ryhanen and colleagues.24  Their 257 
instrument had 46 items grouped into four subscales related to physical, psychological, social 258 
and spiritual well-being. A 10-point Likert scale was used with 0 indicating the worst outcome 259 
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and 10 the best outcome. An overall QOL score was created by summing the subscale variables 260 
and calculating the mean values.41  261 
 262 
Although our focus was on the improvement in quality of life of cancer patients who received a 263 
telehealth intervention for emotional or symptom management support, it is important to note 264 
that telehealth increases access to care for cancer patients, as well as for those suffering from 265 
other chronic conditions. Rural patients are at higher risk for decreased access to specialized 266 
care, and telehealth has been found to increase access to quality care. Telehealth can ease the 267 
burden of travel time, cost, and the discomfort that may be associated with long travel times.42,43 268 
Telehealth can also overcome issues related to ethnicity, culture, and language that affect health, 269 
by facilitating access to culturally competent providers and interpreters.43 270 
 271 
Our study should be interpreted in the context of certain limitations. Our meta-analysis had a 272 
small sample size of manuscripts and patient pools, and thus we were unable to perform a 273 
moderator analysis to determine if alternative factors influenced the effectiveness of treatment 274 
delivery. On a similar note, different cancers, stage of cancer and treatment protocols may have 275 
varying impacts on QOL, which we were unable to explore due to the limited number of studies. 276 
44–46 A study on the factors affecting the quality of life of cancer patients undergoing 277 
chemotherapy found worse quality of life in breast cancer, head and neck, sarcoma, lung and 278 
gynecological cancers. Colorectal cancer patients were found to have the better quality of life. 46 279 
Lower quality of life in breast cancer patients may be due to changes in self-image due to 280 
surgery and hair loss, as well as decreased sexual function and early menopause. Similarly, head 281 
and neck cancers and sarcomas surgical treatment can lead to disfigurement and cause lower 282 
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quality of life for patients.46 In addition, we were unable to effectively assess manuscript quality 283 
as part of our analysis as there was a range of study designs included. Due to the low sample, we 284 
chose to include all studies relevant to our inclusion criteria and agreed upon by author 285 
consensus, regardless of design. Because of inconsistent and limited published data, we erred on 286 
the conservative side when necessary during effect size calculations; however, this only occurred 287 
for two studies, Pfeifer et al. (2015) and Hegel et al. (2011). 22,27 288 
 289 
CONCLUSIONS 290 
Our systematic-review with meta-analysis demonstrated that supplementary interventions 291 
through telehealth have a comparable impact on quality of life scores relative to in-person usual 292 
care. Utilizing telehealth, may allow clinicians and healthcare systems to increase access for 293 
those cancer patients who lack the means to travel for additional treatment or are rurally located 294 
creating increase travel costs and time. Some of the studies in this meta-analysis did see 295 
improvements in other areas such as depression, anxiety, and emotional, social, and physical 296 
well-being, even when overall quality of life was not statistically significantly improved.  Our 297 
findings suggest more studies need to be conducted on the impact of telehealth interventions 298 
across different cancer diagnoses to gain better insight into the differential effect these 299 
interventions may have on quality of life for cancer patients undergoing treatment. 300 
  301 
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